Search research articles
Contact Us
Filters
Showing results (221-230 of 429) with videos related to
Page
of 43
Sort By:
Plos Genetics
|
February 2, 2018
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk
Rosalie G Waller, Todd M Darlington, Xiaomu Wei, et al.
Gynecologic Oncology
|
August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2020
Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel Adenocarcinoma
Alicia Latham, Jinru Shia, Zalak Patel, et al.
JAMA Network Open
|
July 12, 2021
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer
Geoffrey Y Ku, Yelena Kemel, Steve B Maron, et al.
BMJ Open
|
October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial
Salma Shickh, Marc Clausen, Chloe Mighton, et al.
Breast Cancer Research : BCR
|
March 28, 2006
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
Eitan Friedman, Joanne Kotsopoulos, Jan Lubinski, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial
Yvonne Bombard, Marc Clausen, Salma Shickh, et al.
NPJ Breast Cancer
|
November 10, 2017
Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
NPJ Breast Cancer
|
June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Page
of 43
Search research articles
Search
Showing results (221-230 of 429) with videos related to
Sort By:
Page
of 43
Plos Genetics
|
February 2, 2018
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk
Rosalie G Waller, Todd M Darlington, Xiaomu Wei, et al.
Gynecologic Oncology
|
August 14, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Tiffany Y Sia, Sara Moufarrij, Juliet Milani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2020
Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel Adenocarcinoma
Alicia Latham, Jinru Shia, Zalak Patel, et al.
JAMA Network Open
|
July 12, 2021
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer
Geoffrey Y Ku, Yelena Kemel, Steve B Maron, et al.
BMJ Open
|
October 10, 2019
Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial
Salma Shickh, Marc Clausen, Chloe Mighton, et al.
Breast Cancer Research : BCR
|
March 28, 2006
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
Eitan Friedman, Joanne Kotsopoulos, Jan Lubinski, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 12, 2019
Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial
Yvonne Bombard, Marc Clausen, Salma Shickh, et al.
NPJ Breast Cancer
|
November 10, 2017
Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
NPJ Breast Cancer
|
June 27, 2017
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, et al.
Page
of 43